Standout Papers

Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy 2023 2026 202453
  1. Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy (2023)
    Carolyn E. Cesta, Ran S. Rotem et al. JAMA Internal Medicine

Immediate Impact

2 by Nobel laureates 57 standout
Sub-graph 1 of 21

Citing Papers

Risk of Autism after Prenatal Topiramate, Valproate, or Lamotrigine Exposure
2024 Standout
Targeting the incretin system in obesity and type 2 diabetes mellitus
2024 Standout
1 intermediate paper

Works of Carolyn E. Cesta being referenced

Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy
2023 Standout
A common data model for harmonization in the Nordic Pregnancy Drug Safety Studies (NorPreSS)
2021

Author Peers

Author Last Decade Papers Cites
Carolyn E. Cesta 339 271 153 282 51 847
Richard Hackett 291 281 44 289 45 944
Jaden R. Kohn 239 156 129 222 58 825
Katherine E. Williams 249 119 181 230 28 855
Marzieh Saei Ghare Naz 311 195 227 246 80 944
Jessica L. Chan 314 209 103 357 48 952
Samuel S. Thatcher 452 125 88 648 24 900
Figen Kır Şahin 281 190 232 159 60 878
Kajal Khodamoradi 157 74 341 234 48 910
Fulvia Mancini 319 92 84 471 49 837
Frank Falkner 272 244 40 142 57 838

All Works

Loading papers...

Rankless by CCL
2026